Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables RefundsShares OutstandingShort-Term Debt repayments
Ratios

BioNexus Gene Lab (BGLC) Shares Outstanding (2018 - 2025)

Historic Shares Outstanding for BioNexus Gene Lab (BGLC) over the last 8 years, with Q3 2025 value amounting to $1.8 million.

  • BioNexus Gene Lab's Shares Outstanding fell 0.94% to $1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 million, marking a year-over-year decrease of 0.94%. This contributed to the annual value of $1.8 million for FY2024, which is 169.8% up from last year.
  • According to the latest figures from Q3 2025, BioNexus Gene Lab's Shares Outstanding is $1.8 million, which was down 0.94% from $1.8 million recorded in Q2 2025.
  • In the past 5 years, BioNexus Gene Lab's Shares Outstanding ranged from a high of $171.2 million in Q1 2021 and a low of $1.8 million during Q4 2023
  • Its 5-year average for Shares Outstanding is $34.0 million, with a median of $14.3 million in 2021.
  • Per our database at Business Quant, BioNexus Gene Lab's Shares Outstanding tumbled by 9166.67% in 2021 and then surged by 2290.71% in 2023.
  • BioNexus Gene Lab's Shares Outstanding (Quarter) stood at $14.3 million in 2021, then rose by 1.46% to $14.5 million in 2022, then plummeted by 87.8% to $1.8 million in 2023, then grew by 1.7% to $1.8 million in 2024, then fell by 0.01% to $1.8 million in 2025.
  • Its Shares Outstanding stands at $1.8 million for Q3 2025, versus $1.8 million for Q2 2025 and $1.8 million for Q1 2025.